Ultromics
Last verified 2026-05-02. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $55.0Mattributed |
|---|---|
| Latest round | series-c, $55.0M, 2025-07-31attributed |
| Founded | 2017 |
| Headquarters | Oxford, GB |
| Industry | healthtech |
| Stage | series-b+ |
| Website | ultromics.com |
Ultromics builds AI diagnostic tools that analyze routine echocardiograms to detect cardiac conditions like heart failure and amyloidosis. It serves hospitals, clinics, and payers, partnering with Mayo Clinic and Northwestern Medicine. Its edge is FDA-cleared software that returns automated reports in about 20 minutes with no hardware install.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-07-31 | series-c | $55.0M | undisclosed |
Detected tech stack
Cloudflare, Terminus, Linkedin Ads, Linkedin Insight Tag, YouTube, Google Analytics, Google Tag Manager, DoubleClick Floodlight, HubSpot CMS Hub, Cloudflare Bot Management, Cookie Script, web-vitals
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series C, $55.0M | attributed | news-misc named as publisher. No document URL on file. |
| Total raised $55.0M | attributed | news-misc named as publisher. No document URL on file. |
| Company existence | self-reported | ultromics.com, read 2026-05-02 |
| Description | self-reported | ultromics.com, read 2026-05-02 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.